Safety and Immunogenicity Trial of PepGNP-COVID19 Vaccine in Adults
Safety and Immunogenicity Trial of PepGNP-COVID19 Vaccine in Adults
Active, not recruiting · NCT07183709 · Registry updated 2026-05-15Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Safety and Immunogenicity Trial of PepGNP-COVID19 Vaccine in Adults | COVID-19, Coronaviridae Infections, Infections, Nidovirales infectious disease, Orthocoronavirinae infectious disease, RNA Virus Infections, lung disorder, pneumonia, respiratory system disorder, respiratory tract infectious disorder, viral infectious disease, viral pneumonia | Active, not recruiting | Phase 1 | 2026-05-15 | NCT07183709 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| National Institute of Allergy and Infectious Diseases (NIAID) | 402 |
3 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Cincinnati Children's Hospital Medical Center Vaccine Research Center | Cincinnati | United States | 2 |
| George Washington University Medical Faculty Associates | Washington D.C. | United States | 1 |
| University of Alabama at Birmingham School of Medicine - Infectious Disease | Birmingham | United States | 1 |